Skip to main content

Table 2 Spearman coefficients for the correlation between ASES subscales and clinical and psychosocial variables at all available timepoints

From: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis

 

ASES pain

ASES other symptoms

ASES total

DAS28-CRP

−0.35

−0.33

−0.37

HAQ

0.48

0.55

0.55

Pain (VAS)

0.46

0.46

0.50

Fatigue (VAS)

0.45

0.51

0.51

PGA (VAS)

0.46

0.47

0.51

SF-36 PCS

0.58

0.61

0.64

SF-36 MCS

0.33

0.52

0.44

IPQ-R illness coherence

0.37

0.50

0.46

IPQ-R treatment control

0.40

0.46

0.46

IPQ-R personal control

0.29

0.27

0.30

IPQ-R consequences

0.58

0.64

0.65

IPQ-R emotional representations

0.46

0.59

0.56

RAQoL

0.57

0.68

0.67

PhGA (VAS)

−0.32

−0.34

−0.36

TJC28

−0.32

−0.31

−0.34

SJC28

−0.19

−0.17

−0.20

CRP

−0.07

−0.06

−0.07

ESR

−0.07

−0.07

−0.08

  1. ASES Arthritis Self-Efficacy Scale, DAS28 Disease Activity Score in 28 joints, HAQ Health Assessment Questionnaire, VAS visual analogue scale, PGA patient’s global assessment of disease activity, SF-36 Short-Form 36, PCS physical component score, MCS mental component score, IPQ-R Revised Illness Perception Questionnaire, PhGA physician’s global assessment of disease activity, TJC28 tender joint count in 28 joints, SJC28 swollen joint count in 28 joints, CRP C-reactive protein, ESR erythrocyte sedimentation rate